My Account | Shopping Cart | Contact  
Trilink Biotech Logo

Oligonucleotides | mRNA & Long RNA | Nucleotides | CleanCap® | CleanTag® | CleanAmp® | Custom Chemistry | GMP

Resources

FAQs: Ask An Expert
Technical Articles
Bibliography
Education
eNewsletters
Blog: Zone in With Zon
TriLink Publications
Related Services
Research Updates
 

eNewsletters

Sign up for TriLink's eNews today!

Oct 2018 CleanTag® Supports New Method to Detect Reactivation of a Common Virus
Sep 2018 Is DNA Synthesis Going Enzymatic?
Aug 2018 Liquid Biopsy Reveals Promising Biomarkers for Rectal and Brain Cancer Patients
Jul 2018 Closer to a Cure? Elucidating the Structure of the HIV Reverse Transcriptase Initiation Complex
Jun 2018 Post-transcriptional Gene Silencing Goes Nuclear
May 2018 Super GMOs with a Super CRISPR/Cas9
Mar 2018 X-shredding: Man-Made Male
Feb 2018 When Timing is Everything. Uncovering the Temporal Dynamics of RNA Using TimeLapse-seq
Jan 2018 Cancer Marker PD-L1 Leads to a Potential Tool for Studying Metabolic Disorders
Dec 2017 Understanding the Genetic Basis of Skin Pigmentation with CRISPR/Cas9
Nov 2017 Unraveling Cell Specific Muscular Disorders with TriLink’s Cas9
Oct 2017 Cell Specific Snipping with miRNA-Cas9 Switches
Sep 2017 Hit-and-Run Programming with TriLink mRNA
Aug 2017 Detecting & Controlling Protein Expression with mRNA Devices
Jul 2017 Smac’ing Down Tumor Cells with TriLink’s Cas9 mRNA
Jun 2017 MIT Targets Tumors with TriLink Custom and Catalog mRNA
May 2017 Taming Two Beasts with mRNA incorporating TriLink Modified NTPs
Apr 2017 Targeted mRNA Delivery through Novel Polymeric Nanoparticles Confirmed using TriLink EGFP
Mar 2017 CleanTag™ Small RNA-Seq Kits used to Identify Changes in miRNA that Link Gut Microbiota to Intestinal Cell Proliferation
Feb 2017 mRNA Stability Controlled by Dynamic Methylation at Transcription Start Site
Jan 2017 TriLink's Top Products of 2016 and Predictions for 2017
Dec 2016 Restoring Mitochondrial Health After Cellular Stress
Nov 2016 Modified mRNA May Suppress Immune Activation at Multiple Steps of RIG-I Pathway
Oct 2016 COPD Analysis Using CRISPR Technology
Sep 2016 Genome-scale CRISPR Screens Identify Critical Host Factors for Hepatitis C, Dengue, Zika and Other Mosquito-borne Flaviviruses
Aug 2016 Alternative Splicing is Highly Sensitive to Mutation
Jul 2016 Novel Selection Process Leads to Improved Aptamers for HER2-Positive Cancer
Jun 2016 Modified oligos from TriLink used to synthesize polymer-tagged nucleotides for new nanopore sequencing method
May 2016 Promising Treatment for Duchenne Muscular Dystrophy with Antisense Oligo Therapeutic Formulated with Carbohydrates
Apr 2016 mRNA from TriLink Improves CRISPR/Cas9-mediated Gene Repair In Vivo
Mar 2016 2´F-modified RNA from TriLink Used to Modulate the Immune System
Feb 2016 Using Chemistry to Solve Big Biological Questions
Jan 2016 TriLink's Top Products of 2015 and Predictions for 2016
 

eNewsletter Archive

  • Dec 2015: Optimizing Gene Editing with a Combination of mRNA and AAV
  • Nov 2015: Using sRNA Sequencing to Improve Diagnosis and Treatment of Coronary Artery Disease
  • Oct 2015: CleanAmp™ dNTPs Aid in Detection of Intra-amniotic Infections
  • Sep 2015: Chemical Modifications Enhance CRISPR-Cas9 Editing Efficiency
  • Jul 2015: Reducing Risk with mRNA
  • Jun 2015: Stopping the Clock with Modified mRNA
  • May 2015: UV Crosslinking as a Tool to Reveal DNA-Protein Binding
  • Apr 2015: N6-methyladenosine Marks the Site of pri-miRNA Processing
  • Mar 2015: Using CRISPR to Elucidate the Role of RIPK1
  • Feb 2015: RNA Aptamers Target NMDA Receptors
  • Jan 2015: Advancing mRNA Vaccines
  • Dec 2014: Enriching Methylated DNA - New Avenue for Diagnostics
  • Nov 2014: RNA Aptamers May Outsmart Prostate Cancer
  • Oct 2014: Targeting the Host to Bypass Evolution
  • Sep 2014: Improved Blood Viral Detection with CleanAmp™ Primers
  • Aug 2014: New Perspectives on Antisense Oligos
  • Jul 2014: Modified mRNA: Getting to the Heart of Gene Therapy
  • Jun 2014: Reducing NGS Contamination & Smartphone Diagnostics
  • May 2014: Increasing CRISPR/Cas Nuclease Specificity
  • Apr 2014: Tales of Aptamer Selection
  • Mar 2014: Emerging RNA Epigenetics
  • Feb 2014: TALEN mRNA + Sex, Money & Brains
  • Jan 2014: Developing Antibodies Using Oligonucleotide-directed Mutagenesis

  •  

      Twitter Twitter Facebook Facebook Linked In Linked In RSS RSS Google RSS  
    © 2018 TriLink BioTechnologies, LLC | All Rights Reserved